R&D efforts in this area have already achieved several effective treatments against different pathologies
Cancer, infectious diseases, haematology and neurology made up the majority of the new additions, which also included three gene and cell therapies.
One in four positive rulings of the EMA were aimed at treatments for rare diseases
The international federation of the research-based pharmaceutical industry, IFPMA, has renewed its commitment to global health progress in celebration of its 50th anniversary
The pharmaceutical industry can claim several examples of success in recent decades such as vaccines, the fight against HIV and cancer and also the cure for Hepatitis C
In Spain, almost half of the €1,100 million that the pharmaceutical industry invests in R&D is dedicated to collaboration projects with centres and external parties
The Agreement, which will remain in effect throughout 2018, aims to facilitate patient access to therapeutic innovations under equitable conditions and ensure the sustainability of the National Health System
FARMAINDUSTRIA remarks that patients are the raison d'etre for those who are part of the health care system
The associations that represent the European and British biomedical industry insist on the importance of ensuring cooperation between the United Kingdom and the European Union in terms of pharmaceutical regulation
They recognise that the Code of Good Practice "guarantees that relationships with professionals and health organizations are developed under strict ethical principles".
For a second year running, the companies adhering to FARMAINDUSTRIA's Transparency Code publish the collaborations with sector agents
FARMAINDUSTRIA approves its annual report of activities in the Association’s Ordinary General Assembly